Stem Cells

Human neuronal stem cell and iPS cell cultures are of high scientific and practical interest in drug discovery, toxicology and for future therapeutic applications. To understand the differentiation process of these stem cell cultures into neurons is an important and complex task and an essential prerequisite for the functional characterization of test compounds in a human cellular background.

Our offer in service and FTE projects

  • Phenotypic screening of test compounds on human iPSC derived neurons: We have developed and established protocols for human iPSC neurons on MEAs (partly together with our commercial partners who offer iPSC-neurons and NPCs).

get a quote for a pilot study or a library screen

  • Functional characterization of your hiPSC-derived neurons or progenitors: We apply your protocol for culturing neurons or NPCs and screen them during their synaptic and neurogenic development on micro-electrode arrays. Having more than four years of experience with hiPSC neuron recordings, we optimize your culture protocols based on functional activity readout and compare activity with commercially available reference cell lines (download stem cell info sheet).

get a quote for your iPSC line

  • Comparing functional human and mouse phenotype: We have a database of several hundreds to thousands of datasets from mouse tissue-specific neuron cultures. We compare stem cell-derived neuronal network activity patterns with primary cell recordings. This is a powerful tool to characterize tissue-, species- and compound-specific functionality. See our SfN2014 poster on classification of activity patterns from iPSC-derived neuronal networks (see image below).

get a quote for your iPSC line

  • Parkinson’s disease in a dish: We induce disease-associated functional phenotypes into human iPSC neuronal networks for the screening of neuro-protective compounds. We use dopaminergic neuronal networks and functionally impaired them e.g. by recombinant monomeric or filamentous alpha synuclein or low-concentrated MPP+. These disease phenotypes are quantified by multi-parametric data analysis and sophisticated artificial intelligence tools. This allows us to rank rescue efficacy of your compounds in a simple manner (See our AD/PD 2015 poster on phenotypic prevention of functional MPP+ effects by GDNF).

get a quote for your leads and test compounds

  • Functional biomarker screening: we compare human iPSC-derived neurons from healthy individuals with patient-derived cultures and identify disease-related functional parameters. These functional biomarkers allow specific compound screening.

get a quote for your patient or a complete cohort

  • Together with you we establishment specific disease models based on your specific indication and gene of interests.

let’s discuss your ideas